Table 3 Comparison of serum DIDO1-, FOXJ2-, and CPSF2-Ab levels between HDs and patients with acute myocardial infarction (AMI) or diabetes mellitus (DM) examined by AlphaLISA
Alpha analysis (antibody level) | DIDO1-Ab | FOXJ2-Ab | CPSF2-Ab | |
|---|---|---|---|---|
HD | Average | 11,373 | 12,218 | 5571 |
SD | 1939 | 6636 | 2390 | |
Cutoff value | 15,251 | 25,490 | 10,351 | |
Positive no. | 4 | 4 | 7 | |
Positive (%) | 3.1% | 3.1% | 5.5% | |
AMI | Average | 11,634 | 22,965 | 5343 |
SD | 2405 | 16,329 | 3070 | |
Positive no. | 10 | 44 | 6 | |
Positive (%) | 7.8% | 34.4% | 4.7% | |
P (AMI vs HD) | 0.342 | < 0.0001 | 0.508 | |
DM | Average | 11,199 | 21,718 | 7232 |
SD | 2252 | 24,383 | 3798 | |
Positive no. | 7 | 29 | 17 | |
Positive (%) | 5.5% | 22.7% | 13.3% | |
P (DM vs HD) | 0.508 | < 0.0001 | < 0.0001 | |